Fifty years of Weibel–Palade bodies: the discovery and early history of an enigmatic organelle of endothelial cells
Safety of catheter-delivered plasmin in patients with acute lower extremity arterial or bypass graft occlusion: phase I results
Sex hormone-binding globulin as a marker for the thrombotic risk of hormonal contraceptives
The JAK2 V617F mutation in patients with cerebral venous thrombosis
Superficial vein thrombosis and recurrent venous thromboembolism: a pooled analysis of two observational studies
Insulin resistance and risk of venous thromboembolism: results of a population-based cohort study
Predicting disease recurrence in patients with previous unprovoked venous thromboembolism: a proposed prediction score (DASH)
A randomized double-blind study of low-molecular-weight heparin (parnaparin) for superficial vein thrombosis: STEFLUX (Superficial ThromboEmbolism and Fluxum)
Comparison of the Villalta post-thrombotic syndrome score in the ipsilateral vs. contralateral leg after a first unprovoked deep vein thrombosis
Differential sensitivity of von Willebrand factor (VWF) ‘activity’ assays to large and small VWF molecular weight forms: a cross-laboratory study comparing ristocetin cofactor, collagen-binding and mAb-based assays
Validation of Nijmegen–Bethesda assay modifications to allow inhibitor measurement during replacement therapy and facilitate inhibitor surveillance
Heme binds to factor VIII and inhibits its interaction with activated factor IX
Evidence that fibrinogen γ′ directly interferes with protofibril growth: implications for fibrin structure and clot stiffness
Fibrinogen counteracts the antiadhesive effect of fibrin-bound plasminogen by preventing its activation by adherent U937 monocytic cells
Increased zymogen activity of thrombin-activatable fibrinolysis inhibitor prolongs clot lysis
Semaphorin 7A inhibits platelet production from CD34+ progenitor cells
Diannexin, an annexin A5 homodimer, binds phosphatidylserine with high affinity and is a potent inhibitor of platelet-mediated events during thrombus formation
Targeted gene inactivation reveals a functional role of calpain-1 in platelet spreading
ITAM receptor-mediated generation of reactive oxygen species in human platelets occurs via Syk-dependent and Syk-independent pathways
Polyphosphate scores a hat trick in regulating host defense mechanisms
Polyphosphate elicits pro-inflammatory responses that are counteracted by activated protein C in both cellular and animal models
The recombinant bifunctional protein αCD133–GPVI promotes repair of the infarcted myocardium in mice
Tissue factor pathway inhibitor is an inhibitor of factor VII-activating protease
Interlaboratory workshop on anti-HPA-1a alloantibody quantification with the mAb-specific immobilization of platelet antigen technique
Value assignment of the WHO 8th International Standard for factor VIII, concentrate (07/350)
Citalopram is a more potent platelet function inhibitor than paroxetine in a case–control study
Pneumonia and risk of venous thrombosis: results from the MEGA study
Osteoprotegerin levels are increased in patients with venous thromboembolic disease
Microparticles expressing tissue factor are concurrently released with markers of inflammation and coagulation during human endotoxemia
When is it safe to stop for safety?
Novel analysis of clinically relevant diagnostic errors in point-of-care devices: a rebuttal
Novel analysis of clinically relevant diagnostic errors in point-of-care devices: a reply to a rebuttal
Low-molecular-weight heparin added to aspirin in the prevention of recurrent early-onset pre-eclampsia in women with inheritable thrombophilia: the FRUIT-RCT: a rebuttal
Low-molecular-weight heparin added to aspirin in the prevention of recurrent early-onset pre-eclampsia in women with inheritable thrombophilia: the FRUIT-RCT: a reply to a rebuttal
Artificially depleted plasmas are not necessarily commutable with native patient plasmas for International Sensitivity Index calibration and International Normalized Ratio derivation: a rebuttal
Artificially depleted plasmas are not necessarily commutable with native patient plasmas for International Sensitivity Index calibration and International Normalized Ratio derivation: a reply to a rebuttal
Cancers in patients with hemophilia: a retrospective study from the Italian Association of Hemophilia Centers: a rebuttal
Cancers in patients with hemophilia: a retrospective study from the Italian Association of Hemophilia Centers: a reply to a rebuttal
Regulation by TAFI of the survival and apoptosis signals in the hepatocytes
Hypofibrinolysis and cardiovascular disease risk factors in black Africans
Involvement of plasminogen on the repair process after brain damage
Fondaparinux specifically influences the clot quality and fibrinolysis, and not the clotting time
The contribution of fibrinolysis impairment to the development on thrombosis in antiphospholipid syndrome (APS)
Statins do not correct hypofibrinolysis in hypercholesterolemia. correcting LDL-cholest unveils an inverse relation of HDL-cholest and clot lysis time
Anti-platelet aggregation activity of highly purified nattokinase
Hyper coagulation and fibrinolytic activity may cause progressing neurological deficits in patients with acute atherothrombotic stroke
Alteplase induced hypofibrinogenaemia is associated with fibrinogenolysis and not with a rare polymorphism of the major fibrinolytic components
Assessment of preoperative pulmonary embolism on the academic medical center in Japan
Relationship between insulin resistance and some coagulation and fibrinolytic parameters in subjects with metabolic syndrome
Development of a sandwich-type ELISA for the detection of human active thrombin activatable fibrinolysis inhibitor (TAFIa)
Plasma TPA increases fibrinolytic activity of exogenous uPA: modulating role of fibrinogen and factor XIII
Kinetics and mechanism of inhibition by angiostatin of plasminogen activation under action of plasminogen activators
Role of the serpin protease nexin-1, in tissue remodelling occurring during pulmonary fibrosis
Trans-regulation of chemokines and its relationship with uPA during C-phycocyanin stimulation. Implication on fibroblast cell migration
Anti-fibrinolytic function of proanthocyanidin-rich grape seed extract: influence on plasminogen activator system
Effects of Shochu's aromatic components on tissue plasminogen activator (t-PA) release and platelet aggregation activities
Evaluation of some hemostatic parameters in patients with end-stage renal disease: relation to dyslipidemia and hemodialysis therapy
Fibrinolytic activity in the IgG fraction of a patient with antiphospholipid syndrome
Novel mutations in the fibrinogen genes causing various coagulation disorders
Altered fibrin clot properties are associated with residual vein obstruction
Prediction of intraoperative blood loss during orthognathic surgery using preoperative thrombelastography
Fibrinogen concentrate as first-line haemostatic therapy during aortic replacement surgery. A randomised trial
Identification of a role for factor XIII in the antifibrinolytic effect of complement C3
The effect of factor XIII and other regulators of fibrinolysis on the outcome of thrombolysis in ischemic stroke patients
Homocysteine plasma levels influence fibrinolytic capacity but not in vitro cleavage of fibrin in pulmonary embolism patients
D-dimer and fibrinolytic activity in patients with liver cirrhosis and ascites. Preliminary results
Successful pregnancy outcome in a woman with dysfibrinogenemia and FV leiden associated with thrombosis
Impact of short term anti-retroviral therapy (START) on some fibrinolytic markers in some HIV infected adults
Evaluation of the inhibition of a recombinantly modified human plasmin in human plasma
Interplay between Kupffer cells and non-Kupffer cell TNF signalling in liver PAI-1 production
U-PA plays a critical role in the induction of macrophage polarity during liver repair
Development of ELISAs to detect full-length and C-terminally intact alpha-2-antiplasmin
Fibrinogen induces autoimmunity and inflammatory cell recruitment
Activated protein C prevents the thrombin-induced activation of astrocytes
Gp1b-alpha blockade restores cerebral arterial patency after occlusive thrombosis
MMP-10 as a new profibrinolytic agent in experimental stroke through TAFI-mediated mechanism
Molecular requirements for a safer generation of thrombolytics by bioengineering the tissue plasminogen activator (TPA) A chain
On the efficacy of direct thrombolytics
Statins enhance vein recanalisation and reduce vein wall inflammation following venous thrombosis
Urokinase-type plasminogen activator and plasminogen activator inhibitor type-1 is increased by interleukin-33 in human endothelial cells
C1 esterase inhibitor misfolding induces powerful activation of the contact pathway
Polyphosphate stabilises factor XIIa and acts as a cofactor in factor XIIa-mediated plasminogen activation
Exploring the relationship between streptococcal virulence and plasminogen activation efficiency
Fibrinolytic activity of microvesicles: a compensatory mechanism in clot formation/dissolution
Urokinase-type plasminogen activator receptor (uPAR) regulates angiogenesis via interaction with low density lipoprotein receptor-(LDLR-) like proteins
Establishment of method and image analysis systems to monitor clot formation and FXIII activity in real time using a murine in vivo model of thrombosis
Antibody therapy targeting tPA's neurotoxicity: a new hope for the treatment of stroke
Increased zymogen activity of thrombin activatable fibrinolysis inhibitor prolongs clot lysis
Platelet factor XIII stabilises thrombi against premature fibrin degradation
PAR1-dependent regulation of mast cell functions in acute inflammation in rats
Plasminogen receptor expressed on the growthpromoted hepatocytes as a putative TAFI substrate during liver regeneration
Accelerated fibrinolysis on vascular endothelial cells triggered by membrane-retained secreted TPA
Synergistic effect of thrombin and CD40I on endothelial MMP-10 expression and microparticle generation in vitro and in vivo
Effect of ageing on the murine venous circulation
Novel role of the urokinase receptor in regulating PTEN levels and its role in angiogenesis
PCI/PAI-3: a plasminogen activator inhibitor or a serpin with other (intracellular) functions?
Hepatocyte growth factor activator inhibitor-2 resides primarily intracellularly to facilitate cell surface transport of matriptase
GSK-3β regulates PAI-1 expression, cell migration and angiogenesis via FBW7 and USP-28-dependent degradation of HIF-1α
Elucidating novel urokinase-type plasminogen activator inhibitors
The effect of DNA and histones on fibrin structure and the regulation of plasminogen activation and fibrinolysis
Bispecific inhibition of TAFI and PAI-1 as a fibrinolytic enhancer
A TAFI-derived peptide enhances TAFI activation by the serine proteases thrombin, plasmin and trypsin
TAFI deficiency plays a predominant role in the hyperfibrinolytic state observed in mice with combined TAFI and PAI-1 gene deficiency
More on the effect of oral anticoagulant treatment on TAFI/TAFIa levels and clot resistance to fibrinolysis
Fibrinolysis alterations in infertile women during controlled ovarian stimulation: influence of BMI and genetic components
Difference in fibrinolytic potential between young patients with venous or arterial thrombosis is not explained by PAI
Biological mechanisms responsible for MRI T1 relaxation in venous thrombosis
Hemostasis, adhesion and clot stability characteristics of human fibrinogen produced in the milk of transgenic cows
Remodeling of clots without proteolytic digestion
Fibrinolysis at the interface of blood vessel wall and thrombi
Decreased fibrinolytic resistance of plasma clots containing red blood cells
Fibrin-targeted molecular MRI identifies venous thrombi susceptible to thrombolysis
Diabetes modulates the fibrinolytic properties of aspirin without altering the platelet inhibitory actions: a possible mechanism for aspirin treatment failure
On the opposing effects of factor XIIa on clot stability
Investigating sources of factor XIIIa specificity for glutamine-containing substrates
Kringle domains of plasmin are essential for efficient degradation of fibrin but not fibrinogen
The X-ray crystal structure of full-length human plasminogen
Retarded tissue plasminogen activator and facilitated plasmin action in fibrin modified by carboxypeptidase B
Impact of fibrin structure on fibrinolysis by different plasminogen activators: studies using fluorescent confocal microscopy
Fibrinolysis in liver disease
Plasminogen activation and neuronal biology
Update on the 3rd international stroke trial; effects of thrombolysis among 3035 stroke patients within 6 h of onset
The role of the fibrinolytic system as a virulence determinant of Streptococcus pyogenes
The plasminogen receptor, Plg-RKT, regulates cell surface plasminogen activation and cell migration
Membrane-anchored serine proteases and their inhibitors
Plasminogen activation and cancer: blocking of plasmin-mediated cdcp1 cleavage in vivo prevents AKT-dependent survival of cancer cells and inhibits metastatic colonization
Fibrinolysis, new concepts, new mechanisms: microvesicles and fibrinolytic crosstalk
D-dimer and other laboratory tests in DIC
TAFI structure and function
Diagnostic markers as predictors of disease
Pathophysiology of atherosclerosis
Fibrinogen and β-amyloid association alters thrombosis and fibrinolysis: a possible contributing factor to Alzheimer's disease
Fibrin clot structure and fibrinolysis